Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KNC Laboratories CoTSE:6568 -1.82%81 Days Payable is 18.63 as of Mar. 2026, which is 9% below its 10-year median of 20.51. GuruFocus rates TSE:6568 with a GF Score™ of 81/100 and a GF Value™ of 円1,294.38 (Fairly Valued). The stock has 9 warning signs investors should review. Among 1,554 Chemicals companies, KNC Laboratories Co ranks worse than 89.38% on this metric.
The historical rank and industry rank for KNC Laboratories Co's Days Payable or its related term are showing as below:
TSE:6568'
s Days Payable Range Over the Past 10 Years
Min: 18.26 Med: 20.51 Max: 45.4
Current: 21.24
During the past 11 years, KNC Laboratories Co's highest Days Payable was 45.40. The lowest was 18.26. And the median was 20.51.
TSE:6568's Days Payable is ranked worse than 89.38% of 1554
companies
in the Chemicals industry
Industry Median: 59.875
vs TSE:6568: 21.24
KNC Laboratories Co's Days Payable
increased
from Mar. 2025 (17.72) to Mar. 2026 (18.63).
It may suggest that KNC Laboratories Codelayed paying its suppliers.
KNC Laboratories Co Days Payable Related Terms
KNC Laboratories Co Days Payable Historical Data
* Premium members only.
The historical data trend for KNC Laboratories Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, KNC Laboratories Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KNC Laboratories Co Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, KNC Laboratories Co's Days Payable distribution charts can be found below:
* The bar in red indicates where KNC Laboratories Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
KNC Laboratories Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNC Laboratories Co (TSE:6568) has a Days Payable of 18.63 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on KNC Laboratories Co and its competitors. This is near median its historical median of 20.51. Over the past decade, KNC Laboratories Co's Days Payable has ranged from 18.26 to 45.40. According to the industry distribution chart, KNC Laboratories Co ranks #1389 out of 1554 companies in the Chemicals industry, placing it in the top 89.4%.
Is KNC Laboratories Co's Days Payable too high?
KNC Laboratories Co's current Days Payable of 18.63 is near median its 10-year median of 20.51. Over the past 10 years, this metric has ranged from a low of 18.26 to a high of 45.40. The Chemicals industry median Days Payable is 59.88. KNC Laboratories Co's value of 18.63 is 68.9% below this industry median. Based on the distribution chart, KNC Laboratories Co ranks #1389 out of 1554 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, KNC Laboratories Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KNC Laboratories Co's Days Payable compare to DOW?
According to the Chemicals industry distribution chart, KNC Laboratories Co ranks #1389 out of 1554 companies for Days Payable. This places KNC Laboratories Co in the lower half of its industry. The industry median Days Payable is 59.88. KNC Laboratories Co's value of 18.63 is 68.9% below this benchmark. Historically, KNC Laboratories Co's own Days Payable has ranged from 18.26 to 45.40 over the past decade. While the company's 10-year median is 20.51 vs. the industry median of 59.88, KNC Laboratories Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.88, based on 1,554 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KNC Laboratories Co's current Days Payable of 18.63 is 68.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on KNC Laboratories Co and its competitors. For the Chemicals industry, the median Days Payable is 59.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KNC Laboratories Co's current Days Payable is 18.63, which is near median its own 10-year median of 20.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KNC Laboratories Co stock overvalued right now?
Based on GuruFocus' analysis, KNC Laboratories Co (TSE:6568) is currently considered Fairly Valued. The stock's GF Value™ is 円1,294.38, compared to a current price of 円1,296.00 — trading 0.1% above its estimated fair value. The current Days Payable is 18.63, which is near median its 10-year median of 20.51 and 68.9% below the Chemicals industry median of 59.88. KNC Laboratories Co's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For KNC Laboratories Co (TSE:6568), the current Days Payable is 18.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KNC Laboratories Co (TSE:6568) Overvalued in 2026?
Based on GuruFocus' analysis, KNC Laboratories Co stock appears to be overvalued.
The current stock price of 円1,296.00 is trading 0.1% above its estimated GF Value™ of 円1,294.38.
GuruFocus considers KNC Laboratories Co to be Fairly Valued.
Key valuation signals for TSE:6568:
Days Payable: 18.63 (near median its 10-year median of 20.51)
GF Value™: 円1,294.38 vs. price of 円1,296.00 (0.1% above fair value)
Industry Position: 68.9% below the Chemicals median (#1389 of 1554)
No single metric tells the full story. See the TSE:6568 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6568 has been successfully added to your 
